지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 170 - 175 (6page)
이용수
초록· 키워드
오류제보하기
Atherosclerosis arising from the pro-inflammatory conditionsassociated with chronic kidney disease (CKD) increases majorcardiovascular morbidity and mortality. Rapamycin (RAPA) isknown to inhibit atherosclerosis under CKD and non-CKD conditions,but it can cause dyslipidemia; thus, the co-application oflipid-lowering agents is recommended. Atorvastatin (ATV) hasbeen widely used to reduce serum lipids levels, but its synergisticeffect with RAPA in CKD remains unclear. Here, we analyzedthe effect of their combined treatment on atherosclerosis stimulatedby CKD in apolipoprotein E-deficient (ApoE?/?) mice. OilRed O staining revealed that treatment with RAPA and RAPA＋ATV, but not ATV alone, significantly decreased the atheroscleroticlesions in the aorta and aortic sinus, compared to those seen inthe control (CKD) group. The co-administration of RAPA and ATVimproved the serum lipid profile and raised the expressionlevels of proteins involved in reverse cholesterol transport (LXR?,CYP7A1, ABCG1, PPAR?, ApoA1) in the liver. The CKD groupshowed increased levels of various genes encoding atherosclerosispromotingcytokines in the spleen (Tnf-?, Il-6 and Il-1?) and aorta(Tnf-? and Il-4), and these increases were attenuated by RAPAtreatment. ATV and RAPA＋ATV decreased the levels of Tnf-?and Il-1? in the spleen, but not in the aorta. Together, theseresults indicate that, in CKD-induced ApoE?/? mice, RAPA significantlyreduces the development of atherosclerosis by regulatingthe expression of inflammatory cytokines and the co-applicationof ATV improves lipid metabolism.
목차
등록된 정보가 없습니다.
참고문헌 (40)
참고문헌 신청
London GM / 1997 / Atherosclerosis and arteriosclerosis in chronic renal failure / Kidney Int 51:1678~1695
Zoccali C / 2015 / Con : vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease / Nephrol Dial Transplant 30:352~357
Himmelfarb J / 2002 / The elephant in uremia : oxidant stress as a unifying concept of cardiovascular disease in uremia / Kidney Int 62:1524~1538
Ketteler M / 2006 / Calcification and cardiovascular health : new insights into an old phenomenon / Hypertension 47:1027~1034
Finch JL / 2013 / Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification / Kidney Int 84:1145~1153
Zoccali C / 2015 / Con : vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease / Nephrol Dial Transplant 30:352~357
Himmelfarb J / 2002 / The elephant in uremia : oxidant stress as a unifying concept of cardiovascular disease in uremia / Kidney Int 62:1524~1538
Ketteler M / 2006 / Calcification and cardiovascular health : new insights into an old phenomenon / Hypertension 47:1027~1034
Finch JL / 2013 / Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification / Kidney Int 84:1145~1153
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet
Experimental and Molecular Medicine
2015 .01
-
The role of the farnesoid X receptor in kidney health and disease: a potential therapeutic target in kidney diseases
Experimental and Molecular Medicine
2023 .02
-
Dyslipidemia promotes germinal center reactions via IL-27
BMB Reports
2018 .01
-
TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia
Experimental and Molecular Medicine
2023 .02
-
The implications of signaling lipids in cancer metastasis
Experimental and Molecular Medicine
2018 .01
-
Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells
BMB Reports
2019 .01
-
LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
BMB Reports
2018 .01
-
Nanomedicine for the Treatment of Atherosclerosis
한국생물공학회 학술대회
2021 .10
-
The Study of Chronic Kidney Disease Classification using KHANES data
한국컴퓨터정보학회 학술발표논문집
2020 .01
-
원격 제어 ATV 시스템의 통신 및 제어부 구성에 관한 연구
대한전자공학회 학술대회
2016 .06
-
Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway
Experimental and Molecular Medicine
2024 .09
-
원격제어 ATV 시스템의 구동기 선정 및 소비전력에 관한 연구
대한전자공학회 학술대회
2016 .06
-
Guarana Extract Improves Lipid Metabolism in 3T3-L1 and High-fat Diet Mouse Model
한국생물공학회 학술대회
2022 .04
-
Loss of RTN3 phenocopies chronic kidney disease and results in activation of the IGF2-JAK2 pathway in proximal tubular epithelial cells
Experimental and Molecular Medicine
2022 .05
-
Biomimetic Prohealing Nanomatrix for Stent and Atherosclerosis Model
한국고분자학회 학술대회 연구논문 초록집
2021 .04
-
무인 주행 ATV를 위한 브레이크 제어기구 설계에 관한 연구
대한전자공학회 학술대회
2016 .06
-
Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
Experimental and Molecular Medicine
2020 .01
-
신장장애인의 자살생각 관련요인
보건정보통계학회지
2018 .01
-
중·고령자의 주요 만성질환 유병인구 예측: Future Elderly Model을적용
보건정보통계학회지
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0